Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Nitric Oxide in Mild COPD
NCT04069052Phase 1Completed
- Start
- Sep 2021
- Primary completion
- May 2023
- Modality
- DNA Intercalators/Alkylators, Inhalation Devices
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing Inhaled Nitric Oxide with Placebo (2 arms). Primary endpoints: Dyspnea Intensity and Inspiratory neural drive. Started Sep 2021; status: completed.
02
Drugs
nitric oxide
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT04069052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04069052.